Drug recall · September 7, 2022
Timolol Maleate Ophthalmic Solution recall
Why: Failed Impurities/Degradation Specifications: Identification of an unknown impurity at the 12-month stability point.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Timolol Maleate Ophthalmic Solution, USP, 0.5%, 5 x 0.3 mL Single-Dose Vials, Rx Only, Sterile, Manufactured for: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-189-24
- Lots / codes
Lot #: 9N72, EXP 09/30/2022
- Quantity
- 5,226 Cartons (60 vials/carton)
- Company
- Akorn, Inc, Gurnee, IL
- Distribution
- Distributed Nationwide in the USA
- Initiated
- August 8, 2022 · Voluntary: Firm initiated
- Classified
- August 29, 2022
- Reported
- September 7, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.